Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 04 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-04-2024-2

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 04, 2024, titled "Zydus receives tentative approval from USFDA for Azilsartan Medoxomil Tablets, 40 mg and 80 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases